{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:00:13Z","timestamp":1781917213809,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.eimc.2014.04.016","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T17:03:09Z","timestamp":1406221389000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Training should be the first step toward an antifungal stewardship program"],"prefix":"10.1016","volume":"33","author":[{"given":"Maricela","family":"Valerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodr\u00edguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sanjurjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Guinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2014.04.016_bib0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/653616","article-title":"Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center","volume":"31","author":"Apisarnthanarak","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.eimc.2014.04.016_bib0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/587633","article-title":"Inappropriate use of antifungal medications in a tertiary care center in Thailand: a prospective study","volume":"29","author":"Sutepvarnon","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.eimc.2014.04.016_bib0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/37.1.175","article-title":"An audit of the use of antifungal agents","volume":"37","author":"Gutierrez","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic antifungal therapy in critically ill patients without invasive fungal infection","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2014.04.016_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0040","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2014.04.016_bib0045","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s00134-002-1540-y","article-title":"Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination","volume":"28","author":"Garbino","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.eimc.2014.04.016_bib0050","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1097\/01.CCM.0000074724.71242.88","article-title":"Fluconazole improves survival in septic shock: a randomized double-blind prospective study","volume":"31","author":"Jacobs","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2014.04.016_bib0055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients","volume":"233","author":"Pelz","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.eimc.2014.04.016_bib0060","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.CCM.0000178352.14703.49","article-title":"Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis","volume":"33","author":"Shorr","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2014.04.016_bib0065","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dki491","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials","volume":"57","author":"Playford","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/QCO.0b013e3283177967","article-title":"Antifungals in the ICU","volume":"21","author":"Playford","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0075","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death","volume":"65","author":"Slavin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0080","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.00479-10","article-title":"Risk factors for fluconazole-resistant candidemia","volume":"54","author":"Garnacho-Montero","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0100","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","article-title":"Candidaemia in Europe: epidemiology and resistance","volume":"27","author":"Tortorano","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2014.04.016_bib0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13693780802415556","article-title":"Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?","volume":"47","author":"Guinea","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.eimc.2014.04.016_bib0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0732-8893(02)00432-7","article-title":"Frequency and clinical significance of bloodstream infections caused by C. albicans strains with reduced susceptibility to fluconazole","volume":"44","author":"Munoz","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0120","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1128\/AAC.49.8.3171-3177.2005","article-title":"and the fluconazole dose\/MIC ratio correlate with therapeutic response among patients with candidemia","volume":"49","author":"Clancy","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/AAC.00474-06","article-title":"Association of fluconazole area under the concentration-time curve\/MIC and dose\/MIC ratios with mortality in nonneutropenic patients with candidemia","volume":"51","author":"Pai","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0130","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1128\/AAC.00116-08","article-title":"Association of fluconazole pharmacodynamics with mortality in patients with candidemia","volume":"52","author":"Baddley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0135","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1128\/AAC.00296-07","article-title":"Correlation of the MIC and dose\/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia","volume":"51","author":"Rodriguez-Tudela","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.04.016_bib0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.19.2.435-447.2006","article-title":"Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing","volume":"19","author":"Pfaller","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2014.04.016_bib0145","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/JCM.43.5.2075-2079.2005","article-title":"Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital","volume":"43","author":"Bouza","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2014.04.016_bib0150","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2014.04.016_bib0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2014.04.016_bib0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.04.016_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FTD.0b013e318167d0e0","article-title":"Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations","volume":"30","author":"Smith","year":"2008","journal-title":"Ther Drug Monit"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14002055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14002055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T11:20:48Z","timestamp":1538392848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X14002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0213005X14002055"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2014.04.016","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Training should be the first step toward an antifungal stewardship program","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2014.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}